Trials / Terminated
TerminatedNCT03274999
Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use
Randomized, Controlled, Single-Center, Cross-Over Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the change in tear meniscus height (TMH) produced by intranasal stimulation with TrueTear™ compared with the same device applied extranasally (control).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TrueTear™ Application | Intranasal and extranasal application of TrueTear™ device for approximately 3 minutes at Day 0 and Day 14. |
Timeline
- Start date
- 2017-10-18
- Primary completion
- 2017-11-09
- Completion
- 2017-11-09
- First posted
- 2017-09-07
- Last updated
- 2021-03-08
- Results posted
- 2021-03-08
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03274999. Inclusion in this directory is not an endorsement.